- Investing Ideas
- U.K. Healthcare Undervalued over 20% based on DCF
U.K. Healthcare Undervalued over 20% based on DCF
Results
6
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
6 companies
Smith & Nephew
Market Cap: UK£9.8b
Develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
SN.
UK£11.37
7D
0.4%
1Y
2.4%
CVS Group
Market Cap: UK£868.5m
Engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia.
CVSG
UK£12.24
7D
-2.6%
1Y
-3.9%
NIOX Group
Market Cap: UK£244.8m
Engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide.
NIOX
UK£0.57
7D
-6.2%
1Y
-14.8%
Tristel
Market Cap: UK£184.7m
Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.
TSTL
UK£3.90
7D
4.0%
1Y
2.6%
EKF Diagnostics Holdings
Market Cap: UK£106.8m
Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.
EKF
UK£0.26
7D
-4.1%
1Y
-3.8%
EMV Capital
Market Cap: UK£13.6m
A venture capital firm specializing in seed, growth capital, early and mid stage investments.
EMVC
UK£0.48
7D
0%
1Y
4.3%